The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial
Abstract
OBJECTIVE: To determine the effectiveness of systematic screening with a brief 19-item self-report instrument, the Adverse Events Profile (AEP), to reduce adverse effects of antiepileptic drugs (AEDs) and improve subjective health status. METHODS: The authors performed a prospective randomized trial comparing the use of the AEP with usual care without the AEP. Sixty-two patients with an AEP score of >or=45 were enrolled from a consecutive group of 200 consenting adults with epilepsy. RESULTS: The mean percent improvement in AEP scores was greater in the patient group for which clinicians received the AEP compared with the usual care group (25% vs 5%; p < 0.01). Mean change in Quality of Life in Epilepsy Inventory (QOLIE)-89 total scores was not different between groups, but for the entire sample QOLIE-89 change was greater for patients having a 15-point improvement in AEP scores than for those with a 0- to 15-point improvement or a worsened score (24 vs 12 vs 3; analysis of variance, p < 0.008). More patients in the AEP group had a >15-point improvement in QOLIE-89 score (p < 0.03). Use of the AEP was associated with a 2.8-fold increase (95% CI, 1.7 to 4.8) in AED modifications. No difference in seizure rates was observed. CONCLUSIONS: Systematic screening for antiepileptic drug side effects may increase identification of toxicity and guide medication changes to reduce adverse effects and possibly improve subjective health status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mattson, R. H., Cramer, J. A., Collins, J. F., Smith, D. B., Delgado-Escueta, A. V., Browne, T. R., Williamson, P. D., Treiman, D. M., McNamara, J. O., McCutchen, C. B., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130303 · Cited by 1,138
Quality of life of people with epilepsy: a European study
Baker, G. A., Jacoby, A., Buck, D., Stalgis, C., & Monnet, D. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01128.x · Cited by 847
Self-citationDevelopment of the Quality of Life in Epilepsy Inventory
Devinsky, O., Vickrey, B. G., Cramer, J., Perrine, K., Hermann, B., Meador, K., & Hays, R. D. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00467.x · Cited by 634
Outcomes Research: Measuring the End Results of Health Care
Clancy, C. M., & Eisenberg, J. M. (1998) · Science · doi:10.1126/science.282.5387.245 · Cited by 324
Heller, A. J., Chesterman, P., Elwes, R. D., Crawford, P., Chadwick, D., Johnson, A. L., & Reynolds, E. H. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.1.44 · Cited by 257
Hermann, B. P., Vickrey, B., Hays, R. D., Cramer, J., Devinsky, O., Meador, K., Perrine, K., Myers, L. W., & Ellison, G. W. (1996) · Epilepsy Research · doi:10.1016/0920-1211(96)00024-1 · Cited by 218
New Antiepileptic Drugs: Comparison of Key Clinical Trials
Cramer, J. A., Fisher, R., Ben‐Menachem, E., French, J., & Mattson, R. H. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb05561.x · Cited by 187
Commission on Outcome Measurement in Epilepsy, 1994–1997: Final Report
Baker, G. A., Camfield, C., Camfield, P., Cramer, J. A., Elger, C. E., Johnson, A. L., Martins da Silva, A., Meinardi, P. H., Munari, C., Perucca, E., et al. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01361.x · Cited by 161
Self-citationVickrey, B. G., Hays, R. D., Rausch, R., Sutherling, W. W., Engel, J., & Brook, R. H. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02480.x · Cited by 160
Cited by
Adverse effects of antiepileptic drugs
Perucca, P., & Gilliam, F. G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70153-9 · Cited by 694
Self-citationDepression but not seizure frequency predicts quality of life in treatment-resistant epilepsy
Boylan, L. S., Flint, L. A., Labovitz, D. L., Jackson, S. C., Starner, K., & Devinsky, O. (2004) · Neurology · doi:10.1212/01.wnl.0000103282.62353.85 · Cited by 644
Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan
Lin, J. J., Mula, M., & Hermann, B. P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61455-x · Cited by 435
The pharmacological treatment of epilepsy in adults
Perucca, E., & Tomson, T. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70047-3 · Cited by 334
Luoni, C., Bisulli, F., Canevini, M. P., De Sarro, G., Fattore, C., Galimberti, C. A., Gatti, G., La Neve, A., Muscas, G., Specchio, L. M., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03325.x · Cited by 287
Metadata
- Authors
- Gilliam, F. G., Fessler, A. J., Baker, G., Vahle, V., Carter, J., & Attarian, H.
- Venue
- Neurology
- Published
- 2004-01-13
- Volume
- 62
- Issue
- 1
- Pages
- 23-27
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2017924471
- Cited by
- 340
- References
- 13
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial. https://app.cochat.ai/papers/10.1212/wnl.62.1.23
- The paper
- Gilliam, F. G., Fessler, A. J., Baker, G., Vahle, V., Carter, J., & Attarian, H. (2004). Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial. Neurology. https://doi.org/10.1212/wnl.62.1.23
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.